review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1015036753 |
P356 | DOI | 10.1186/2001-1326-1-9 |
P932 | PMC publication ID | 3560991 |
P698 | PubMed publication ID | 23369517 |
P5875 | ResearchGate publication ID | 235390377 |
P2093 | author name string | Xiangdong Wang | |
Chunxue Bai | |||
Xiaocong Fang | |||
P2860 | cites work | Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans | Q25255098 |
NMR structure of lung surfactant peptide SP-B(11-25) | Q27639402 | ||
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network | Q27861021 | ||
Quantitative monitoring of gene expression patterns with a complementary DNA microarray | Q27861102 | ||
Metabolic profiles of cancer cells | Q28269762 | ||
Advances in molecular acute lung injury/acute respiratory distress syndrome and ventilator-induced lung injury: the role of genomics, proteomics, bioinformatics and translational biology | Q37057186 | ||
Vascular endothelial growth factor receptor and coreceptor expression in human acute respiratory distress syndrome. | Q37231665 | ||
A simple clinical predictive index for objective estimates of mortality in acute lung injury. | Q37316778 | ||
Recent progress of proteomics in critical illness | Q37357877 | ||
Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death | Q37401041 | ||
What is metabolomics all about? | Q37500593 | ||
Biomarkers of lung-related diseases: current knowledge by proteomic approaches | Q37579765 | ||
Metabolic effects of albumin therapy in acute lung injury measured by proton nuclear magnetic resonance spectroscopy of plasma: a pilot study | Q37595364 | ||
Caveolin-1: a critical regulator of lung injury | Q37811611 | ||
Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair. | Q37874843 | ||
Bioinformatic-driven search for metabolic biomarkers in disease | Q37925151 | ||
Activating transcription factor 3 confers protection against ventilator-induced lung injury. | Q38344617 | ||
Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury | Q40154556 | ||
Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury. | Q41991828 | ||
Matrix metalloproteinases: all the RAGE in the acute respiratory distress syndrome | Q42715259 | ||
Clinical bioinformatics: a new emerging science | Q42735788 | ||
Cancer bioinformatics: a new approach to systems clinical medicine | Q43245365 | ||
-308GA and TNFB polymorphisms in acute respiratory distress syndrome | Q45298329 | ||
Fas-mediated acute lung injury requires fas expression on nonmyeloid cells of the lung | Q47732319 | ||
Incidence of acute lung injury in the United States. | Q47851035 | ||
Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality | Q47874594 | ||
Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury | Q47885086 | ||
Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. | Q51585412 | ||
Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. | Q51705583 | ||
Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. | Q52454638 | ||
Interactive instruction on population interactions | Q52800449 | ||
Quantitative metabolomics using NMR | Q57014388 | ||
Bronchoalveolar lavage fluid peptidomics suggests a possible matrix metalloproteinase-3 role in bronchopulmonary dysplasia | Q57745611 | ||
Incidence, management and mortality of acute hypoxemic respiratory failure and acute respiratory distress syndrome from a prospective study of Chinese paediatric intensive care network | Q82621780 | ||
The influence of genetic variation in surfactant protein B on severe lung injury in African American children | Q83334881 | ||
Incidence and outcomes of pediatric acute lung injury | Q84141441 | ||
Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury | Q28566123 | ||
NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice | Q28588550 | ||
The acute respiratory distress syndrome | Q29615140 | ||
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data | Q29784220 | ||
Surfactant protein B: structure and function. | Q30342031 | ||
Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury | Q30478475 | ||
Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome | Q30483815 | ||
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis | Q30483818 | ||
Genetic Variation in theFASGene and Associations with Acute Lung Injury | Q30498604 | ||
Outcome prediction in pneumonia induced ALI/ARDS by clinical features and peptide patterns of BALF determined by mass spectrometry. | Q31032368 | ||
Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. | Q32032889 | ||
Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. | Q33197095 | ||
Bioinformatics methods for learning radiation-induced lung inflammation from heterogeneous retrospective and prospective data | Q33496450 | ||
Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury | Q33595107 | ||
Pulmonary pathology of acute respiratory distress syndrome | Q34053375 | ||
High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness | Q34305430 | ||
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop | Q34386133 | ||
Metabolic consequences of sepsis-induced acute lung injury revealed by plasma 1H-nuclear magnetic resonance quantitative metabolomics and computational analysis | Q34502201 | ||
Non-muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury. | Q34526565 | ||
From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest | Q34528902 | ||
Genetic ablation of phagocytic NADPH oxidase in mice limits TNFα-induced inflammation in the lungs but not other tissues | Q34958620 | ||
ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. | Q35042517 | ||
Protein analysis on a proteomic scale | Q35084572 | ||
Disease proteomics | Q35084579 | ||
Haplotype association mapping of acute lung injury in mice implicates activin a receptor, type 1 | Q35107680 | ||
Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology | Q35205810 | ||
The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival. | Q35544693 | ||
Interleukin-1 receptor-associated kinase 3 gene associates with susceptibility to acute lung injury | Q35692077 | ||
Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway | Q35820717 | ||
RAGE (receptor for advanced glycation end products): a central player in the inflammatory response | Q35920321 | ||
Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis | Q35944590 | ||
Proteomics in pulmonary medicine | Q36561447 | ||
Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics | Q36607286 | ||
Epidemiology and outcomes of acute lung injury. | Q36734407 | ||
Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury | Q36808033 | ||
P433 | issue | 1 | |
P921 | main subject | bioinformatics | Q128570 |
acute respiratory distress syndrome | Q344873 | ||
P304 | page(s) | 9 | |
P577 | publication date | 2012-06-09 | |
P1433 | published in | Clinical and translational medicine | Q27724586 |
P1476 | title | Bioinformatics insights into acute lung injury/acute respiratory distress syndrome | |
P478 | volume | 1 |
Q40711913 | Effects of anti-human T lymphocyte immune globulins in patients: new or old. |
Q37562317 | Gene polymorphisms and chronic obstructive pulmonary disease |
Q34457014 | Identification of novel single nucleotide polymorphisms associated with acute respiratory distress syndrome by exome-seq |
Q37260532 | Potential effects of medicinal plants and secondary metabolites on acute lung injury |
Q26750469 | Potentials of single-cell biology in identification and validation of disease biomarkers |
Q42820143 | Preventive effects of dexmedetomidine on the liver in a rat model of acid-induced acute lung injury. |
Q37370819 | Regulatory mechanisms of TGF-β1-induced fibrogenesis of human alveolar epithelial cells |
Q34410351 | Telocytes in the urinary system |
Search more.